MILabs

Executive Summary

MILabs is a Netherlands-based medical technology company that specializes in high-resolution, modular preclinical imaging systems integrating SPECT, PET, CT, and optical modalities. Founded in 2006, the company addresses the growing demand for reliable and reproducible data in preclinical research, with applications in neurobiology, oncology, and cardiovascular disease. By offering a unified workflow that reduces complexity, MILabs aims to accelerate scientific discovery for researchers worldwide. As a private, pre-clinical stage company, MILabs operates in a niche but critical segment of the diagnostics and medical devices market, with a strong focus on innovation and customer-centric solutions. Its technology platform has the potential to become a standard tool in preclinical imaging, though commercialization and market penetration remain key challenges.

Upcoming Catalysts (preview)

• Q4 2026Launch of next-generation integrated imaging system70% success
• Q2 2027Strategic partnership with a major pharmaceutical company50% success
• Q3 2026Expansion into the Asian preclinical research market60% success